STOCK TITAN

[SCHEDULE 13D/A] Oxbridge Re Holdings Limited Warrant expiring 3/26/2029 SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Oxbridge Re Holdings Ltd. (Ticker: OXBRW) – Schedule 13D/A (Amendment No. 2)

The filing updates the beneficial ownership of a coordinated reporting group led by Allan S. Martin and related entities. The group now controls a combined 964,422 ordinary shares (12.07% of outstanding) through direct holdings and warrant-exercisable shares. Key ownership breakdown:

  • Allan S. Martin: 964,422 shares (incl. 547,298 warrant-exercisable), sole voting/dispositive power 0; shared 964,422.
  • Marie B. Martin: 424,697 shares (5.53%), sole voting/dispositive 34,664; shared 390,033.
  • Fleur de Lis Partners, LLLP: 317,770 shares (4.13%), all shared voting/dispositive.
  • Allan S Martin Children’s IRRV Trust: 34,664 shares (≈1%).
  • Martin Family Foundation, Inc.: 146,723 shares (≈1%).

The securities were acquired with personal funds “for investment purposes.” No plans for corporate actions are disclosed.

Recent transactions (Schedule A, past 60 days):

  • Open-market sales: four blocks of 1,000 shares each on 3 Jul 2025 at weighted prices between $2.0312–$2.1350.
  • Inter-family transfer: 25,000-share gift on 7 Jul 2025 from Allan & Marie Martin to the Martin Family Foundation; reciprocal transfer recorded for reporting purposes.

Following these trades, Mr. Martin remains the largest outside shareholder, exceeding the 5% threshold that triggers 13D reporting. The filing contains no new financing arrangements, litigation, or proposals affecting control. All signatories certified the accuracy of the statement on 7 Jul 2025.

Oxbridge Re Holdings Ltd. (Ticker: OXBRW) – Schedule 13D/A (Emendamento n. 2)

La dichiarazione aggiorna la proprietà effettiva di un gruppo di segnalazione coordinato guidato da Allan S. Martin e entità correlate. Il gruppo controlla ora complessivamente 964.422 azioni ordinarie (12,07% del capitale in circolazione) attraverso partecipazioni dirette e azioni esercitabili da warrant. Ripartizione principale della proprietà:

  • Allan S. Martin: 964.422 azioni (incl. 547.298 esercitabili da warrant), potere di voto/dispositivo esclusivo 0; condiviso 964.422.
  • Marie B. Martin: 424.697 azioni (5,53%), potere di voto/dispositivo esclusivo 34.664; condiviso 390.033.
  • Fleur de Lis Partners, LLLP: 317.770 azioni (4,13%), tutto potere di voto/dispositivo condiviso.
  • Allan S Martin Children’s IRRV Trust: 34.664 azioni (circa 1%).
  • Martin Family Foundation, Inc.: 146.723 azioni (circa 1%).

I titoli sono stati acquisiti con fondi personali “a scopo di investimento.” Non sono stati comunicati piani per azioni societarie.

Transazioni recenti (Schedule A, ultimi 60 giorni):

  • Vendite sul mercato aperto: quattro blocchi da 1.000 azioni ciascuno il 3 luglio 2025 a prezzi ponderati tra $2,0312 e $2,1350.
  • Trasferimento inter-familiare: donazione di 25.000 azioni il 7 luglio 2025 da Allan & Marie Martin alla Martin Family Foundation; trasferimento reciproco registrato a fini di segnalazione.

A seguito di queste operazioni, il Sig. Martin rimane il maggiore azionista esterno, superando la soglia del 5% che obbliga alla segnalazione 13D. Il deposito non contiene nuovi accordi finanziari, contenziosi o proposte che influenzino il controllo. Tutti i firmatari hanno certificato l’accuratezza della dichiarazione il 7 luglio 2025.

Oxbridge Re Holdings Ltd. (Ticker: OXBRW) – Schedule 13D/A (Enmienda No. 2)

La presentación actualiza la propiedad beneficiaria de un grupo coordinado de reporte liderado por Allan S. Martin y entidades relacionadas. El grupo ahora controla un total combinado de 964,422 acciones ordinarias (12,07% del total en circulación) mediante participaciones directas y acciones ejercitables por warrants. Desglose clave de la propiedad:

  • Allan S. Martin: 964,422 acciones (incl. 547,298 ejercitables por warrants), poder de voto/dispositivo exclusivo 0; compartido 964,422.
  • Marie B. Martin: 424,697 acciones (5,53%), poder de voto/dispositivo exclusivo 34,664; compartido 390,033.
  • Fleur de Lis Partners, LLLP: 317,770 acciones (4,13%), todo poder de voto/dispositivo compartido.
  • Allan S Martin Children’s IRRV Trust: 34,664 acciones (aprox. 1%).
  • Martin Family Foundation, Inc.: 146,723 acciones (aprox. 1%).

Los valores fueron adquiridos con fondos personales “con fines de inversión.” No se divulgan planes para acciones corporativas.

Transacciones recientes (Schedule A, últimos 60 días):

  • Ventas en mercado abierto: cuatro bloques de 1,000 acciones cada uno el 3 de julio de 2025 a precios ponderados entre $2.0312 y $2.1350.
  • Transferencia inter-familiar: regalo de 25,000 acciones el 7 de julio de 2025 de Allan & Marie Martin a la Martin Family Foundation; transferencia recíproca registrada para fines de reporte.

Tras estas operaciones, el Sr. Martin sigue siendo el mayor accionista externo, superando el umbral del 5% que activa la presentación 13D. El documento no contiene nuevos acuerdos financieros, litigios o propuestas que afecten el control. Todos los firmantes certificaron la exactitud de la declaración el 7 de julio de 2025.

Oxbridge Re Holdings Ltd. (티커: OXBRW) – Schedule 13D/A (수정안 번호 2)

이 신고서는 Allan S. Martin 및 관련 단체가 이끄는 조정 보고 그룹의 실질 소유권을 업데이트합니다. 해당 그룹은 현재 직접 보유 및 워런트 행사 가능한 주식을 통해 총 964,422주(발행 주식의 12.07%)를 보유하고 있습니다. 주요 소유 내역은 다음과 같습니다:

  • Allan S. Martin: 964,422주 (워런트 행사 가능 주식 547,298주 포함), 단독 의결권 및 처분권 0; 공동 의결권 및 처분권 964,422주.
  • Marie B. Martin: 424,697주 (5.53%), 단독 의결권 및 처분권 34,664주; 공동 390,033주.
  • Fleur de Lis Partners, LLLP: 317,770주 (4.13%), 모두 공동 의결권 및 처분권.
  • Allan S Martin Children’s IRRV Trust: 34,664주 (약 1%).
  • Martin Family Foundation, Inc.: 146,723주 (약 1%).

증권은 개인 자금으로 “투자 목적”으로 취득되었습니다. 기업 활동 계획은 공개되지 않았습니다.

최근 거래 내역 (Schedule A, 최근 60일):

  • 장외 매도: 2025년 7월 3일에 각각 1,000주씩 4개 블록, 가중평균 가격 $2.0312~$2.1350 사이.
  • 가족 간 이전: 2025년 7월 7일 Allan & Marie Martin이 Martin Family Foundation에 25,000주 증여; 보고 목적의 상호 이전 기록.

이 거래들 이후에도 Martin 씨는 5% 보고 기준을 초과하는 최대 외부 주주로 남아 있습니다. 신고서에는 새로운 금융 조치, 소송 또는 지배권에 영향을 미치는 제안이 포함되어 있지 않습니다. 모든 서명자는 2025년 7월 7일 진술서의 정확성을 인증했습니다.

Oxbridge Re Holdings Ltd. (Symbole : OXBRW) – Schedule 13D/A (Amendement n° 2)

Le dépôt met à jour la propriété bénéficiaire d’un groupe de déclaration coordonné dirigé par Allan S. Martin et des entités associées. Le groupe contrôle désormais un total combiné de 964 422 actions ordinaires (12,07 % des actions en circulation) via des participations directes et des actions exerçables par bons de souscription. Répartition clé de la propriété :

  • Allan S. Martin : 964 422 actions (dont 547 298 exerçables par bons), pouvoir de vote/disposition exclusif 0 ; partagé 964 422.
  • Marie B. Martin : 424 697 actions (5,53 %), pouvoir de vote/disposition exclusif 34 664 ; partagé 390 033.
  • Fleur de Lis Partners, LLLP : 317 770 actions (4,13 %), tous pouvoirs de vote/disposition partagés.
  • Allan S Martin Children’s IRRV Trust : 34 664 actions (environ 1 %).
  • Martin Family Foundation, Inc. : 146 723 actions (environ 1 %).

Les titres ont été acquis avec des fonds personnels « à des fins d’investissement ». Aucun plan d’action corporative n’est divulgué.

Transactions récentes (Schedule A, 60 derniers jours) :

  • Ventes sur le marché libre : quatre blocs de 1 000 actions chacun le 3 juillet 2025 à des prix pondérés entre 2,0312 $ et 2,1350 $.
  • Transfert intra-familial : don de 25 000 actions le 7 juillet 2025 d’Allan & Marie Martin à la Martin Family Foundation ; transfert réciproque enregistré à des fins de déclaration.

À la suite de ces opérations, M. Martin reste le principal actionnaire externe, dépassant le seuil de 5 % qui déclenche la déclaration 13D. Le dépôt ne contient pas de nouveaux accords financiers, litiges ou propositions affectant le contrôle. Tous les signataires ont certifié l’exactitude de la déclaration le 7 juillet 2025.

Oxbridge Re Holdings Ltd. (Ticker: OXBRW) – Schedule 13D/A (Änderung Nr. 2)

Die Meldung aktualisiert das wirtschaftliche Eigentum einer koordinierten Meldegruppe unter Leitung von Allan S. Martin und verbundenen Einheiten. Die Gruppe kontrolliert nun insgesamt 964.422 Stammaktien (12,07 % der ausstehenden Aktien) durch Direktbesitz und ausübungsberechtigte Aktien aus Warrants. Wichtige Eigentumsaufteilung:

  • Allan S. Martin: 964.422 Aktien (inkl. 547.298 ausübbarer Warrants), alleiniges Stimm- und Verfügungsrecht 0; gemeinsames Stimm- und Verfügungsrecht 964.422.
  • Marie B. Martin: 424.697 Aktien (5,53 %), alleiniges Stimm- und Verfügungsrecht 34.664; gemeinsam 390.033.
  • Fleur de Lis Partners, LLLP: 317.770 Aktien (4,13 %), alle Stimm- und Verfügungsrechte gemeinsam.
  • Allan S Martin Children’s IRRV Trust: 34.664 Aktien (ca. 1 %).
  • Martin Family Foundation, Inc.: 146.723 Aktien (ca. 1 %).

Die Wertpapiere wurden mit persönlichen Mitteln „zu Investitionszwecken“ erworben. Es sind keine Pläne für Unternehmensmaßnahmen bekanntgegeben.

Jüngste Transaktionen (Schedule A, letzte 60 Tage):

  • Verkäufe am offenen Markt: vier Blöcke mit jeweils 1.000 Aktien am 3. Juli 2025 zu gewichteten Preisen zwischen $2,0312 und $2,1350.
  • Familieninterne Übertragung: Schenkung von 25.000 Aktien am 7. Juli 2025 von Allan & Marie Martin an die Martin Family Foundation; Gegenseitige Übertragung zu Meldezwecken erfasst.

Nach diesen Transaktionen bleibt Herr Martin der größte externe Aktionär und überschreitet die 5%-Schwelle, die eine 13D-Meldung auslöst. Die Meldung enthält keine neuen Finanzierungsvereinbarungen, Rechtsstreitigkeiten oder Vorschläge, die die Kontrolle betreffen. Alle Unterzeichner bestätigten die Richtigkeit der Erklärung am 7. Juli 2025.

Positive
  • Insider group retains a substantial 12.1% stake, indicating ongoing commitment and alignment with shareholders.
Negative
  • Disclosure of four small open-market sales (total 4,000 shares) could be interpreted as light profit-taking by insiders.

Insights

TL;DR – Large insider group still owns 12%+; only minor sales & a charitable transfer disclosed.

The amendment reconfirms significant insider alignment: Allan S. Martin and related entities collectively exceed 12% ownership, well above the Schedule 13D trigger. The small (4,000-share) open-market sales represent <1% of the group’s stake and are unlikely to shift control dynamics. The 25,000-share gift simply reallocates shares within the family network (to the Foundation) without reducing combined exposure. No activism signals or change-in-control intentions are stated, making the filing largely routine. Overall market impact should be muted; however, investors may view the high continuing stake as evidence of long-term commitment.

Oxbridge Re Holdings Ltd. (Ticker: OXBRW) – Schedule 13D/A (Emendamento n. 2)

La dichiarazione aggiorna la proprietà effettiva di un gruppo di segnalazione coordinato guidato da Allan S. Martin e entità correlate. Il gruppo controlla ora complessivamente 964.422 azioni ordinarie (12,07% del capitale in circolazione) attraverso partecipazioni dirette e azioni esercitabili da warrant. Ripartizione principale della proprietà:

  • Allan S. Martin: 964.422 azioni (incl. 547.298 esercitabili da warrant), potere di voto/dispositivo esclusivo 0; condiviso 964.422.
  • Marie B. Martin: 424.697 azioni (5,53%), potere di voto/dispositivo esclusivo 34.664; condiviso 390.033.
  • Fleur de Lis Partners, LLLP: 317.770 azioni (4,13%), tutto potere di voto/dispositivo condiviso.
  • Allan S Martin Children’s IRRV Trust: 34.664 azioni (circa 1%).
  • Martin Family Foundation, Inc.: 146.723 azioni (circa 1%).

I titoli sono stati acquisiti con fondi personali “a scopo di investimento.” Non sono stati comunicati piani per azioni societarie.

Transazioni recenti (Schedule A, ultimi 60 giorni):

  • Vendite sul mercato aperto: quattro blocchi da 1.000 azioni ciascuno il 3 luglio 2025 a prezzi ponderati tra $2,0312 e $2,1350.
  • Trasferimento inter-familiare: donazione di 25.000 azioni il 7 luglio 2025 da Allan & Marie Martin alla Martin Family Foundation; trasferimento reciproco registrato a fini di segnalazione.

A seguito di queste operazioni, il Sig. Martin rimane il maggiore azionista esterno, superando la soglia del 5% che obbliga alla segnalazione 13D. Il deposito non contiene nuovi accordi finanziari, contenziosi o proposte che influenzino il controllo. Tutti i firmatari hanno certificato l’accuratezza della dichiarazione il 7 luglio 2025.

Oxbridge Re Holdings Ltd. (Ticker: OXBRW) – Schedule 13D/A (Enmienda No. 2)

La presentación actualiza la propiedad beneficiaria de un grupo coordinado de reporte liderado por Allan S. Martin y entidades relacionadas. El grupo ahora controla un total combinado de 964,422 acciones ordinarias (12,07% del total en circulación) mediante participaciones directas y acciones ejercitables por warrants. Desglose clave de la propiedad:

  • Allan S. Martin: 964,422 acciones (incl. 547,298 ejercitables por warrants), poder de voto/dispositivo exclusivo 0; compartido 964,422.
  • Marie B. Martin: 424,697 acciones (5,53%), poder de voto/dispositivo exclusivo 34,664; compartido 390,033.
  • Fleur de Lis Partners, LLLP: 317,770 acciones (4,13%), todo poder de voto/dispositivo compartido.
  • Allan S Martin Children’s IRRV Trust: 34,664 acciones (aprox. 1%).
  • Martin Family Foundation, Inc.: 146,723 acciones (aprox. 1%).

Los valores fueron adquiridos con fondos personales “con fines de inversión.” No se divulgan planes para acciones corporativas.

Transacciones recientes (Schedule A, últimos 60 días):

  • Ventas en mercado abierto: cuatro bloques de 1,000 acciones cada uno el 3 de julio de 2025 a precios ponderados entre $2.0312 y $2.1350.
  • Transferencia inter-familiar: regalo de 25,000 acciones el 7 de julio de 2025 de Allan & Marie Martin a la Martin Family Foundation; transferencia recíproca registrada para fines de reporte.

Tras estas operaciones, el Sr. Martin sigue siendo el mayor accionista externo, superando el umbral del 5% que activa la presentación 13D. El documento no contiene nuevos acuerdos financieros, litigios o propuestas que afecten el control. Todos los firmantes certificaron la exactitud de la declaración el 7 de julio de 2025.

Oxbridge Re Holdings Ltd. (티커: OXBRW) – Schedule 13D/A (수정안 번호 2)

이 신고서는 Allan S. Martin 및 관련 단체가 이끄는 조정 보고 그룹의 실질 소유권을 업데이트합니다. 해당 그룹은 현재 직접 보유 및 워런트 행사 가능한 주식을 통해 총 964,422주(발행 주식의 12.07%)를 보유하고 있습니다. 주요 소유 내역은 다음과 같습니다:

  • Allan S. Martin: 964,422주 (워런트 행사 가능 주식 547,298주 포함), 단독 의결권 및 처분권 0; 공동 의결권 및 처분권 964,422주.
  • Marie B. Martin: 424,697주 (5.53%), 단독 의결권 및 처분권 34,664주; 공동 390,033주.
  • Fleur de Lis Partners, LLLP: 317,770주 (4.13%), 모두 공동 의결권 및 처분권.
  • Allan S Martin Children’s IRRV Trust: 34,664주 (약 1%).
  • Martin Family Foundation, Inc.: 146,723주 (약 1%).

증권은 개인 자금으로 “투자 목적”으로 취득되었습니다. 기업 활동 계획은 공개되지 않았습니다.

최근 거래 내역 (Schedule A, 최근 60일):

  • 장외 매도: 2025년 7월 3일에 각각 1,000주씩 4개 블록, 가중평균 가격 $2.0312~$2.1350 사이.
  • 가족 간 이전: 2025년 7월 7일 Allan & Marie Martin이 Martin Family Foundation에 25,000주 증여; 보고 목적의 상호 이전 기록.

이 거래들 이후에도 Martin 씨는 5% 보고 기준을 초과하는 최대 외부 주주로 남아 있습니다. 신고서에는 새로운 금융 조치, 소송 또는 지배권에 영향을 미치는 제안이 포함되어 있지 않습니다. 모든 서명자는 2025년 7월 7일 진술서의 정확성을 인증했습니다.

Oxbridge Re Holdings Ltd. (Symbole : OXBRW) – Schedule 13D/A (Amendement n° 2)

Le dépôt met à jour la propriété bénéficiaire d’un groupe de déclaration coordonné dirigé par Allan S. Martin et des entités associées. Le groupe contrôle désormais un total combiné de 964 422 actions ordinaires (12,07 % des actions en circulation) via des participations directes et des actions exerçables par bons de souscription. Répartition clé de la propriété :

  • Allan S. Martin : 964 422 actions (dont 547 298 exerçables par bons), pouvoir de vote/disposition exclusif 0 ; partagé 964 422.
  • Marie B. Martin : 424 697 actions (5,53 %), pouvoir de vote/disposition exclusif 34 664 ; partagé 390 033.
  • Fleur de Lis Partners, LLLP : 317 770 actions (4,13 %), tous pouvoirs de vote/disposition partagés.
  • Allan S Martin Children’s IRRV Trust : 34 664 actions (environ 1 %).
  • Martin Family Foundation, Inc. : 146 723 actions (environ 1 %).

Les titres ont été acquis avec des fonds personnels « à des fins d’investissement ». Aucun plan d’action corporative n’est divulgué.

Transactions récentes (Schedule A, 60 derniers jours) :

  • Ventes sur le marché libre : quatre blocs de 1 000 actions chacun le 3 juillet 2025 à des prix pondérés entre 2,0312 $ et 2,1350 $.
  • Transfert intra-familial : don de 25 000 actions le 7 juillet 2025 d’Allan & Marie Martin à la Martin Family Foundation ; transfert réciproque enregistré à des fins de déclaration.

À la suite de ces opérations, M. Martin reste le principal actionnaire externe, dépassant le seuil de 5 % qui déclenche la déclaration 13D. Le dépôt ne contient pas de nouveaux accords financiers, litiges ou propositions affectant le contrôle. Tous les signataires ont certifié l’exactitude de la déclaration le 7 juillet 2025.

Oxbridge Re Holdings Ltd. (Ticker: OXBRW) – Schedule 13D/A (Änderung Nr. 2)

Die Meldung aktualisiert das wirtschaftliche Eigentum einer koordinierten Meldegruppe unter Leitung von Allan S. Martin und verbundenen Einheiten. Die Gruppe kontrolliert nun insgesamt 964.422 Stammaktien (12,07 % der ausstehenden Aktien) durch Direktbesitz und ausübungsberechtigte Aktien aus Warrants. Wichtige Eigentumsaufteilung:

  • Allan S. Martin: 964.422 Aktien (inkl. 547.298 ausübbarer Warrants), alleiniges Stimm- und Verfügungsrecht 0; gemeinsames Stimm- und Verfügungsrecht 964.422.
  • Marie B. Martin: 424.697 Aktien (5,53 %), alleiniges Stimm- und Verfügungsrecht 34.664; gemeinsam 390.033.
  • Fleur de Lis Partners, LLLP: 317.770 Aktien (4,13 %), alle Stimm- und Verfügungsrechte gemeinsam.
  • Allan S Martin Children’s IRRV Trust: 34.664 Aktien (ca. 1 %).
  • Martin Family Foundation, Inc.: 146.723 Aktien (ca. 1 %).

Die Wertpapiere wurden mit persönlichen Mitteln „zu Investitionszwecken“ erworben. Es sind keine Pläne für Unternehmensmaßnahmen bekanntgegeben.

Jüngste Transaktionen (Schedule A, letzte 60 Tage):

  • Verkäufe am offenen Markt: vier Blöcke mit jeweils 1.000 Aktien am 3. Juli 2025 zu gewichteten Preisen zwischen $2,0312 und $2,1350.
  • Familieninterne Übertragung: Schenkung von 25.000 Aktien am 7. Juli 2025 von Allan & Marie Martin an die Martin Family Foundation; Gegenseitige Übertragung zu Meldezwecken erfasst.

Nach diesen Transaktionen bleibt Herr Martin der größte externe Aktionär und überschreitet die 5%-Schwelle, die eine 13D-Meldung auslöst. Die Meldung enthält keine neuen Finanzierungsvereinbarungen, Rechtsstreitigkeiten oder Vorschläge, die die Kontrolle betreffen. Alle Unterzeichner bestätigten die Richtigkeit der Erklärung am 7. Juli 2025.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Includes 189,993 ordinary shares held by Allan S Martin and 98,689 ordinary shares held by Allan S. Martin and his wife, Marie Martin, jointly; 83,300 ordinary shares issuable upon the exercise of warrants held by Allan S. Martin and 175,998 ordinary shares issuable upon the exercise of warrants held by Allan S. Martin and his wife, Marie Martin, jointly, that are currently exercisable; 77,986 ordinary shares held by Fleur de Lis Partners, LLLP, and 249,000 ordinary shares issuable upon the exercise of warrants held by Fleur de Lis Partners, LLLP that are currently exercisable. As the general partner of Fleur de Lis Partners, LLLP, Mr. Martin has voting and investment power over the ordinary shares and warrants held by that entity. The amount also includes 96,070 shares held by the Martin Family Foundation, Inc.; and 39,000 ordinary shares issuable upon the exercise of warrants held by the Martin Family Foundation, Inc. that are currently exercisable. Mr. Martin serves on Board of Directors of the Foundation. Includes 173,319 ordinary shares held by Allan S Martin and 67,312 ordinary shares held by Allan S. Martin and his wife, Marie Martin, jointly; 83,300 ordinary shares issuable upon the exercise of warrants held by Allan S. Martin and 175,998 ordinary shares issuable upon the exercise of warrants held by Allan S. Martin and his wife, Marie Martin, jointly, that are currently exercisable; 68,770 ordinary shares held by Fleur de Lis Partners, LLLP, and 249,000 ordinary shares issuable upon the exercise of warrants held by Fleur de Lis Partners, LLLP that are currently exercisable. As the general partner of Fleur de Lis Partners, LLLP, Mr. Martin has voting and investment power over the ordinary shares and warrants held by that entity. The amount also includes 107,723 shares held by the Martin Family Foundation, Inc.; and 39,000 ordinary shares issuable upon the exercise of warrants held by the Martin Family Foundation, Inc. that are currently exercisable. Mr. Martin serves on Board of Directors of the Foundation. Based upon an aggregate of 7,990,220 Issuer ordinary shares of outstanding, consisting of (i) 7,442,922 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 547,298 shares of ordinary shares that may be acquired by exercise of warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
Includes 67,312 ordinary shares held by Allan S. Martin and his wife, Marie Martin, jointly; 175,998 ordinary shares issuable upon the exercise of warrants held by Allan S. Martin and his wife, Marie Martin, jointly, that are currently exercisable. This amount also includes 17,332 shares held by the Allan S Martin Childrens IRRV Trust and 17,332 ordinary shares issuable upon the exercise of warrants held by the Allan S Martin Childrens IRRV Trust that are currently exercisable. Ms. Martin is the sole Trustee for the Trust. The amount also includes 107,723 shares held by the Martin Family Foundation, Inc. and 39,000 ordinary shares issuable upon the exercise of warrants held by the Martin Family Foundation, Inc. that are currently exercisable. Based upon an aggregate of 7,675,252 Issuer ordinary shares of outstanding, consisting of (i) 7,442,922 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 232,330 shares of ordinary shares able to be acquired upon exercise of warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
Includes 68,770 ordinary shares held by Fleur de Lis Partners, LLLP, and 249,000 ordinary shares issuable upon the exercise of warrants held by Fleur de Lis Partners, LLLP that are currently exercisable Based upon an aggregate of 7,691,922 Issuer ordinary shares of outstanding, consisting of (i) 7,442,922 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 249,000 shares of ordinary shares able to be acquired upon exercise of warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
Includes 17,332 shares held by the Allan S Martin Childrens IRRV Trust; and 17,332 ordinary shares issuable upon the exercise of warrants held by the Allan S Martin Childrens IRRV Trust that are currently exercisable. Ms. Martin is the sole trustee of the Trust. Based upon an aggregate of 7,460,254 Issuer ordinary shares of outstanding, consisting of (i) 7,442,922 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 17,332 shares of ordinary shares able to be acquired upon exercise of warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The amount includes 107,723 shares held by the Martin Family Foundation, Inc.; and 39,000 ordinary shares issuable upon the exercise of warrants held by the Martin Family Foundation, Inc. that are currently exercisable. Each of Mr. Allan S. Martin and Mrs. Marie Martin serve on the Board of the Foundation. Based upon an aggregate of 7,481,922 Issuer ordinary shares of outstanding, consisting of (i) 7,442,922 Issuer ordinary shares outstanding as reported by Issuer; and (ii) 39,000 shares of ordinary shares able to be acquired upon exercise of warrants.


SCHEDULE 13D


MARTIN ALLAN S.
Signature:Allan S. Martin
Name/Title:Allan S. Martin
Date:07/07/2025
Marie B. Martin
Signature:Marie B. Martin
Name/Title:Marie B. Martin
Date:07/07/2025
Fleur de Lis Partners, LLLP
Signature:Allan S. Martin
Name/Title:Allan S. Martin, General Partner
Date:07/07/2025
Allan S Martin Childrens IRRV Trust
Signature:Marie B. Martin
Name/Title:Marie B. Martin, Trustee
Date:07/07/2025
Martin Family Foundation, Inc.
Signature:Marie B. Martin
Name/Title:Marie B. Martin, President
Date:07/07/2025

FAQ

Why did Oxbridge Re (OXBRW) insiders file this Schedule 13D/A?

They updated their share counts after minor sales and a 25,000-share gift, keeping ownership data current.

How many Oxbridge Re shares does Allan S. Martin now control?

964,422 ordinary shares, equal to 12.07% of the outstanding stock.

What recent transactions were reported in the filing?

Four 1,000-share open-market sales on 3 Jul 2025 and a 25,000-share gift on 7 Jul 2025.

Do the reporting persons plan to change Oxbridge Re’s strategy or board composition?

No. The filing states the shares were acquired solely for investment purposes with no control intentions disclosed.

How much does Fleur de Lis Partners, LLLP own in OXBRW?

It holds 317,770 shares, representing about 4.13% of the class.

What is the significance of warrant-exercisable shares in the totals?

A combined 547,298 shares included in Mr. Martin’s count can be acquired by exercising warrants, affecting potential dilution.
Oxbridge Re Hldg

NASDAQ:OXBRW

OXBRW Rankings

OXBRW Latest News

OXBRW Latest SEC Filings

OXBRW Stock Data

3.44M
7.44M
Insurance - Reinsurance
Fire, Marine & Casualty Insurance
Link
Cayman Islands
GEORGETOWN